Chemed (CHE)
(Real Time Quote from BATS)
$565.00 USD
-0.52 (-0.09%)
Updated May 20, 2024 09:40 AM ET
4-Sell of 5 4
C Value B Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CHE 565.00 -0.52(-0.09%)
Will CHE be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHE
Should iShares MSCI USA Small-Cap Min Vol Factor ETF (SMMV) Be on Your Investing Radar?
EHC or CHE: Which Is the Better Value Stock Right Now?
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
Chemed (CHE) Q1 Earnings Miss Estimates
Here's Why You Should Retain Chemed (CHE) Stock for Now
Other News for CHE
Chemed: Growth Does Not Justify The Current Stock Price
Chemed CEO McNamara sells 4,000 common shares
Chemed Corp (CHE) CEO Kevin Mcnamara Sells 4,000 Shares
Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Acadia Healthcare (ACHC) and Taysha Gene Therapies (TSHA)
Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2024